Form 4: Oncology Institute Director Sells Shares
Insider Transaction (Form 4)
Brad Hively, a Director of Oncology Institute, Inc., sold 298,853 shares of common stock on August 21, 2026 for $6.51 per share.
Summary
- Open-market sale: disposed of 298,853 Common Stock at $6.51 ($1,946,310) on August 21, 2026; holds 411,976 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,946,310 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Brad Hively — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-21 | Open-market sale | Common Stock | 298,853 | $7 | $1.9M | 411,976 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-21 | Open-market sale (298,853 shares) |
Keywords
insider transaction, Form 4, STLN, Starling Oncology, Inc., bearish, Brad Hively
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.